| Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer SK Saha, CA Parachoniak, KS Ghanta, J Fitamant, KN Ross, MS Najem, ... Nature 513 (7516), 110-114, 2014 | 524 | 2014 |
| Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma D Sia, B Losic, A Moeini, L Cabellos, K Hao, K Revill, D Bonal, ... Nature communications 6 (1), 6087, 2015 | 323 | 2015 |
| Identifying and Treating Refractory ITP: Difficulty in Diagnosis and Role of Combination Treatment Oriana Miltiadous, Ming Hou, James B Bussel Blood, 2019 | 176* | 2019 |
| Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation O Miltiadous, D Sia, Y Hoshida, MI Fiel, AN Harrington, SN Thung, PS Tan, ... Journal of hepatology 63 (6), 1368-1377, 2015 | 91 | 2015 |
| Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease M Burgos da Silva, DM Ponce, A Dai, S M. Devlin, ALC Gomes, G Moore, ... Blood, The Journal of the American Society of Hematology 140 (22), 2385-2397, 2022 | 53 | 2022 |
| Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant O Miltiadous, NR Waters, H Andrlová, A Dai, CL Nguyen, ... Blood, The Journal of the American Society of Hematology 139 (18), 2758-2769, 2022 | 39 | 2022 |
| High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients CL Nguyen, KA Markey, O Miltiadous, A Dai, N Waters, K Sadeghi, T Fei, ... Cell 186 (12), 2705-2718. e17, 2023 | 33 | 2023 |
| MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT H Andrlová, O Miltiadous, AI Kousa, A Dai, S DeWolf, S Violante, HY Park, ... Science translational medicine 14 (646), eabj2829, 2022 | 32 | 2022 |
| Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity M Koyama, DS Hippe, S Srinivasan, SC Proll, O Miltiadous, N Li, P Zhang, ... Immunity 56 (8), 1876-1893. e8, 2023 | 27 | 2023 |
| Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease S Lindner, O Miltiadous, RJF Ramos, J Paredes, AI Kousa, A Dai, T Fei, ... Nature microbiology 9 (3), 614-630, 2024 | 15 | 2024 |
| Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation E Thiele Orberg, E Meedt, A Hiergeist, J Xue, P Heinrich, J Ru, S Ghimire, ... Nature Cancer 5 (1), 187-208, 2024 | 14 | 2024 |
| Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma. Nat Commun 2015; 6: 6087 D Sia, B Losic, A Moeini, L Cabellos, K Hao, K Revill, D Bonal, ... DOI: https://doi. org/10.1038/ncomms7087, 6087, 0 | 12 | |
| Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion–associated myeloid neoplasm O Miltiadous, K Petrova-Drus, S Kaicker, S Mathew, M Kluk, JT Geyer, ... Blood Advances 6 (4), 1137-1142, 2022 | 6 | 2022 |
| Enhanced feature selection for microbiome data using FLORAL: scalable log-ratio lasso regression T Fei, T Funnell, NR Waters, SS Raj, K Sadeghi, A Dai, O Miltiadous, ... bioRxiv, 2023 | 4* | 2023 |
| Immune thrombocytopenia: are we stuck in the mud or is there light at the end of the tunnel? J Bussel, O Miltiadous Clinical Hematology International 1 (4), 173-179, 2019 | 4 | 2019 |
| Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma. Nat Commun 6: 6087 D Sia, B Losic, A Moeini, L Cabellos, K Hao, K Revill, D Bonal, ... | 3 | 2015 |
| Scalable log-ratio lasso regression for enhanced microbial feature selection with FLORAL T Fei, T Funnell, NR Waters, SS Raj, M Baichoo, K Sadeghi, A Dai, ... Cell Reports Methods 4 (11), 2024 | 2 | 2024 |
| MAIT and Vδ2 unconventional T cells predict favorable outcome after allogeneic HCT and are supported by a diverse intestinal microbiome H Andrlova, O Miltiadous, A Dai, R Gardner, S El Daker, JB Slingerland, ... Blood 138, 331, 2021 | 2 | 2021 |
| Mixed hepatocellular-cholangiocarcinoma tumors: stem-cell subtype and cholangiolocellular carcinoma are unique molecular entities A Moeini, D Sia, Z Zhang, G Camprecios, MI Fiel, O Miltiadous, X Sun, ... Hepatology 62, 342A-343A, 2015 | 2 | 2015 |
| O100 DISCOVERY OF NOVEL MUTATIONS AND FUSION PROTEINS IN INTRAHEPATIC CHOLANGIOCARCINOMA D Sia, B Losic, L Cabellos, A Moeini, K Revill, D Bonal, K Hao, ... Journal of Hepatology 60 (1), S41, 2014 | 2 | 2014 |